BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Millán O, Ruiz P, Orts L, Ferré P, Crespo G, Santana M, Fortuna V, Quintairos L, Navasa M, Brunet M. Monitoring of miR-181a-5p and miR-155-5p Plasmatic Expression as Prognostic Biomarkers for Acute and Subclinical Rejection in de novo Adult Liver Transplant Recipients. Front Immunol 2019;10:873. [PMID: 31068943 DOI: 10.3389/fimmu.2019.00873] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Tanimine N, Ohira M, Tahara H, Ide K, Tanaka Y, Onoe T, Ohdan H. Strategies for Deliberate Induction of Immune Tolerance in Liver Transplantation: From Preclinical Models to Clinical Application. Front Immunol 2020;11:1615. [PMID: 32849546 DOI: 10.3389/fimmu.2020.01615] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
2 Celaj S, Levitsky J. Profiling the liver graft. Curr Opin Organ Transplant 2021;26:17-22. [PMID: 33278149 DOI: 10.1097/MOT.0000000000000834] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Taner T, Bruner J, Emamaullee J, Bonaccorsi-Riani E, Zarrinpar A. New Approaches to the Diagnosis of Rejection and Prediction of Tolerance in Liver Transplantation. Transplantation 2022. [PMID: 35594482 DOI: 10.1097/TP.0000000000004160] [Reference Citation Analysis]
4 Cao Q, Li Y, Li Y, Li L. miR-151-5p alleviates corneal allograft rejection by activating PI3K/AKT signaling pathway and balancing Th17/Treg after corneal transplantation via targeting IL-2Rɑ. Ann Transl Med 2021;9:1410. [PMID: 34733962 DOI: 10.21037/atm-21-2054] [Reference Citation Analysis]
5 Millán O, Ruiz P, Fortuna V, Navasa M, Brunet M. Nuclear factor of activated T cells as potential pharmacodynamic biomarker for the risk of acute and subclinical rejection in de novo liver recipients. Liver Int 2020;40:931-46. [PMID: 31883422 DOI: 10.1111/liv.14339] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Aissa AF, Tryndyak VP, de Conti A, Rita Thomazela Machado A, Tuttis K, da Silva Machado C, Hernandes LC, Wellington da Silva Santos P, Mara Serpeloni J, P Pogribny I, Maria Greggi Antunes L. Epigenetic changes induced in mice liver by methionine-supplemented and methionine-deficient diets. Food Chem Toxicol 2022;163:112938. [PMID: 35314295 DOI: 10.1016/j.fct.2022.112938] [Reference Citation Analysis]
7 Fernández-Galán E, Badenas C, Fondevila C, Jiménez W, Navasa M, Puig-Butillé JA, Brunet M. Monitoring of Donor-Derived Cell-Free DNA by Short Tandem Repeats: Concentration of Total Cell-Free DNA and Fragment Size for Acute Rejection Risk Assessment in Liver Transplantation. Liver Transpl 2021. [PMID: 34407295 DOI: 10.1002/lt.26272] [Reference Citation Analysis]
8 Ruiz P, Millán O, Ríos J, Díaz A, Sastre L, Colmenero J, Crespo G, Brunet M, Navasa M. MicroRNAs 155-5p, 122-5p, and 181a-5p Identify Patients With Graft Dysfunction Due to T Cell-Mediated Rejection After Liver Transplantation. Liver Transpl 2020;26:1275-86. [PMID: 32615025 DOI: 10.1002/lt.25842] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Bardhi E, Mcdaniels J, Rousselle T, Maluf DG, Mas VR. Nucleic acid biomarkers to assess graft injury after liver transplantation. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100439] [Reference Citation Analysis]
10 Brunet M, Millán O. Getting immunosuppression just right: the role of clinical biomarkers in predicting patient response post solid organ transplantation. Expert Rev Clin Pharmacol 2021;:1-13. [PMID: 34607521 DOI: 10.1080/17512433.2021.1987882] [Reference Citation Analysis]